President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
Directory of Joslin InvestigatorsDiabetes Research Center Alumni Connection
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowHow You Can Help JoslinHigh Hopes FundGet InvolvedEventsCorporate & Foundation SupportPlanned GivingPhilanthropy Team

Bookmark this page for regular updates!

Hemoglobin A1C – Does it matter?
Read: http://care.diabetesjournals.org/content/40/8/994
Stay tuned for more discussions at Project ECHO@Joslin

Do you re-address medications for patients to promote cardio- vascular health?
Hope you join us soon for this important discussion at Project ECHO@Joslin

Read Sulfonylureas and cardiovascular safety.
http://onlinelibrary.wiley.com/doi/10.1111/dom.12821/full

DPP4 inhibitors and risk of heart failure
http://www.bmj.com/content/bmj/352/bmj.i610.full.pdf
https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0508-8?site=cardiab.biomedcentral.com

GLP-1rAs and SGLT-2 inhibitors
https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-017-0508-8?site=cardiab.biomedcentral.com

Page last updated: December 18, 2017